RecruitingPhase 2NCT06551844

Adaptive Dengue Antiviral Platform Trial

Studying Dengue fever

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oxford University Clinical Research Unit, Vietnam
Principal Investigator
Sophie Yacoub, MD., PhD.
University of Oxford, UK
Intervention
Molnupiravir 400 mg(drug)
Enrollment
500 enrolled
Eligibility
10 years · All sexes
Timeline
2025 – 2030

Study locations (1)

Collaborators

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06551844 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever →

← Back to all trials